FcRn-Dependent Transcytosis of Monoclonal Antibody in Human Nasal Epithelial Cells In Vitro: A Prerequisite for a New Delivery Route for Therapy?
Bequignon, E.; Dhommée, C.; Angely, C.; Thomas, L.; Bottier, M.; Escudier, E.; Isabey, D.; Coste, A.; Louis, B.; Papon, J.-F.; Gouilleux-Gruart, V. FcRn-Dependent Transcytosis of Monoclonal Antibody in Human Nasal Epithelial Cells In Vitro: A Prerequisite for a New Delivery Route for Therapy? Int. J. Mol. Sci. 2019, 20, 1379. https://doi.org/10.3390/ijms20061379
Bequignon E, Dhommée C, Angely C, Thomas L, Bottier M, Escudier E, Isabey D, Coste A, Louis B, Papon J-F, Gouilleux-Gruart V. FcRn-Dependent Transcytosis of Monoclonal Antibody in Human Nasal Epithelial Cells In Vitro: A Prerequisite for a New Delivery Route for Therapy? International Journal of Molecular Sciences. 2019; 20(6):1379. https://doi.org/10.3390/ijms20061379
Chicago/Turabian StyleBequignon, Emilie, Christine Dhommée, Christelle Angely, Lucie Thomas, Mathieu Bottier, Estelle Escudier, Daniel Isabey, André Coste, Bruno Louis, Jean-François Papon, and Valérie Gouilleux-Gruart. 2019. "FcRn-Dependent Transcytosis of Monoclonal Antibody in Human Nasal Epithelial Cells In Vitro: A Prerequisite for a New Delivery Route for Therapy?" International Journal of Molecular Sciences 20, no. 6: 1379. https://doi.org/10.3390/ijms20061379